TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus
- PMID: 20089701
- PMCID: PMC4098568
- DOI: 10.4049/jimmunol.0902592
TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus
Abstract
Systemic lupus erythematosus is characterized by the production of autoantibodies against nucleic acid-associated Ags. We previously found that Tlr7 was required for anti-Sm and Tlr9 for anti-chromatin autoantibodies. Yet, although Tlr7 deficiency ameliorated disease, Tlr9 deficiency exacerbated it. Despite the mechanistic and clinical implications of this finding, it has yet to be elucidated. In this study, we characterize MRL/lpr lupus-prone mice genetically deficient in Tlr7, Tlr9, both Tlr7 and Tlr9, or Myd88 to test whether Tlr7 and Tlr9 function independently or instead regulate each other. We find that disease that is regulated by Tlr9 (and hence is worse in its absence) depends on Tlr7 for its manifestation. In addition, although Tlr7 and Tlr9 act in parallel pathways on different subsets of autoantibodies, Tlr9 also suppresses the production of Tlr7-dependent RNA-associated autoantibodies, suggesting previously unrecognized cross-regulation of autoantibody production as well. By comparing disease in mice deficient for Tlr7 and/or Tlr9 to those lacking Myd88, we also identify aspects of disease that have Tlr- and Myd88-independent components. These results suggest new models for how Tlr9 regulates and Tlr7 enhances disease and provide insight into aspects of autoimmune disease that are, and are not, influenced by TLR signals.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
Similar articles
-
Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.J Immunol. 2014 May 15;192(10):4525-32. doi: 10.4049/jimmunol.1400098. Epub 2014 Apr 7. J Immunol. 2014. PMID: 24711620 Free PMC article.
-
Toll-like receptor 7 (TLR7) modulates anti-nucleosomal autoantibody isotype and renal complement deposition in mice exposed to syngeneic late apoptotic cells.Ann Rheum Dis. 2010 Jun;69(6):1195-9. doi: 10.1136/ard.2009.108282. Epub 2009 Aug 11. Ann Rheum Dis. 2010. PMID: 19674980 Free PMC article.
-
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.Immunity. 2006 Sep;25(3):417-28. doi: 10.1016/j.immuni.2006.07.013. Immunity. 2006. PMID: 16973389
-
Emerging roles of TLR7 and TLR9 in murine SLE.J Autoimmun. 2009 Nov-Dec;33(3-4):231-8. doi: 10.1016/j.jaut.2009.10.001. Epub 2009 Oct 21. J Autoimmun. 2009. PMID: 19846276 Review.
-
Toll-like receptor signalling in B cells during systemic lupus erythematosus.Nat Rev Rheumatol. 2021 Feb;17(2):98-108. doi: 10.1038/s41584-020-00544-4. Epub 2020 Dec 18. Nat Rev Rheumatol. 2021. PMID: 33339987 Free PMC article. Review.
Cited by
-
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.Blood Adv. 2024 Feb 13;8(3):667-680. doi: 10.1182/bloodadvances.2023010362. Blood Adv. 2024. PMID: 38113462 Free PMC article.
-
B cell-intrinsic Myd88 regulates disease progression in murine lupus.J Exp Med. 2023 Dec 4;220(12):e20230263. doi: 10.1084/jem.20230263. Epub 2023 Oct 3. J Exp Med. 2023. PMID: 37787782
-
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.Mol Med. 2023 Sep 4;29(1):117. doi: 10.1186/s10020-023-00717-3. Mol Med. 2023. PMID: 37667233 Free PMC article. Review.
-
B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice.JCI Insight. 2023 Aug 22;8(16):e172219. doi: 10.1172/jci.insight.172219. JCI Insight. 2023. PMID: 37606042 Free PMC article.
-
Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9.Immunohorizons. 2023 Aug 1;7(8):577-586. doi: 10.4049/immunohorizons.2300058. Immunohorizons. 2023. PMID: 37555846 Free PMC article.
References
-
- Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol. 2007;19:3–10. - PubMed
-
- Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251–269. - PubMed
-
- Krug A. Nucleic acid recognition receptors in autoimmunity. Handb Exp Pharmacol. 2008;38:129–151. - PubMed
-
- Kaisho T, Tanaka T. Turning NF-κB and IRFs on and off in DC. Trends Immunol. 2008;29:329–336. - PubMed
-
- Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci. 2008;1143:21–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
